CMMB - Chemomab Therapeutics Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of chemomab.com (CMMB)

Chemomab Therapeutics production capacities are fully utilized for current clinical trials. The trailing 12-month revenue trend on GURU.Markets reflects market expectations, where 0.00 indicates the level of this metric. Chemomab Therapeutics relies on the development of anti-inflammatory antibodies while ensuring a strict temperature-controlled delivery regime for patient safety.

CMMB Chemomab Therapeutics: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 11/18/2026

Chemomab Therapeutics Ltd (CMMB) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Summary company analytics:CMMB - chemomab.com
Mass-produced product of Chemomab Therapeutics Ltd.

The unique CCL24 protein blocking mechanism provides Chemomab Therapeutics (CMMB) with significant pricing power in the fibrosis treatment segment. This market position directly determines the dynamics of the last twelve months (LTM) revenue growth rate. This indicator measures the speed of sales growth over a rolling year, identifying the business's stage of maturity. Stabilizing values signal a transition from expansion to sustainability. Analysis of this chart allows for an assessment of the asset's investment attractiveness.

Who Chemomab Therapeutics competes with

VRTX (Vertex Pharmaceuticals Inc.) - Trailing Twelve Months Sales Growth|Alnylam Pharmaceuticals - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) INSM (Insmed Incorporated)|UTHR: Sales Growth YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BridgeBio Pharma Inc|Revenue Growth YoY (Last 12 Months) BGM Group Ltd (BGM)|Sales Growth YoY (Last Twelve Months) cogentbio.com (COGT)|Revenue Growth YoY (Last 12 Months) Xeris Biopharma XERS|Sales Growth YoY (TTM) KROS (kerostx.com)|Sales Growth YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Sales Growth YoY (TTM)|KMDA - Sales Growth YoY (TTM)|FULC (Fulcrum Corp) - Revenue Growth YoY (Last 12 Months)|ABEO (Abeona Therapeutics, Inc.) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (TTM) PLRX|Sales Growth YoY (Last Twelve Months) APLT (Applied Therapeutics)|Rein Therapeutics Inc - Revenue Growth YoY (Last 12 Months)|Gelteq Limited (GELS) - Trailing Twelve Months Revenue Growth|aytubio.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth srxhealth.com|PLRZ (Polyrizon) - Revenue Growth YoY (Last 12 Months)|Aeterna Zentaris (AEZS) - Sales Growth YoY (TTM)|CYTH (Cyclo Therapeutics) - Sales Growth YoY (TTM)|INZY: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Revenue Dynamics YoY (Last Twelve Months)